OCUP - TellurianNeoGenomics Dave & Buster's Entertainment among premarket losers' pack
NeoGenomics (NEO) -29% on Q1 guidance cut; CEO to quit Progenity (PROG) -22% on Q4 earnings release. Stryve Foods (SNAX) -21% releases inaugural shareholder report. Kala Pharmaceuticals (KALA) -19% on Q4 earnings release. Lipocine (LPCN) -15% its partner received FDA approval of TLANDO™. Lightning eMotors (ZEV) -13% on Q4 earnings release. Marin Software (MRIN) -11%. Conn's (CONN) -10% on Q4 earnings release. Creative Medical Technology (CELZ) -9%. NextDecade (NEXT) -9% on FY earnings release. The OLB Group (OLB) -9% on FY earnings release. Kaixin Auto (KXIN) -8%. Tellurian (TELL) -6%. Sphere 3D (ANY) -6%. Ocuphire Pharma (OCUP) -6% its eye drop Nyxol for reversing pupil dilation meets main goal in 2nd phase 3 trial. Koss (KOSS) -5%. Dave & Buster's Entertainment (PLAY) -5% on Q4 earnings release
For further details see:
Tellurian,NeoGenomics, Dave & Buster's Entertainment among premarket losers' pack